Literature DB >> 17761907

Higher total serum cholesterol levels are associated with less severe strokes and lower all-cause mortality: ten-year follow-up of ischemic strokes in the Copenhagen Stroke Study.

Tom Skyhøj Olsen1, Rune Haubo Bojesen Christensen, Lars Peter Kammersgaard, Klaus Kaae Andersen.   

Abstract

BACKGROUND AND
PURPOSE: Evidence of a causal relation between serum cholesterol and stroke is inconsistent. We investigated the relation between total serum cholesterol and both stroke severity and poststroke mortality to test the hypothesis that hypercholesterolemia is primarily associated with minor stroke.
METHODS: In the study, 652 unselected patients with ischemic stroke arrived at the hospital within 24 hours of stroke onset. A measure of total serum cholesterol was obtained in 513 (79%) within the 24-hour time window. Stroke severity was measured with the Scandinavian Stroke Scale (0=worst, 58=best); a full cardiovascular risk profile was established for all. Death within 10 years after stroke onset was obtained from the Danish Registry of Persons.
RESULTS: Mean+/-SD age of the 513 patients was 75+/-10 years, 54% were women, and the mean+/-SD Scandinavian Stroke Scale score was 39+/-17. Serum cholesterol was inversely and almost linearly related to stroke severity: an increase of 1 mmol/L in total serum cholesterol resulted in an increase in the Scandinavian Stroke Scale score of 1.32 (95% CI, 0.28 to 2.36, P=0.013), meaning that higher cholesterol levels are associated with less severe strokes. A survival analysis revealed an inverse linear relation between serum cholesterol and mortality, meaning that an increase of 1 mmol/L in cholesterol results in a hazard ratio of 0.89 (95% CI, 0.82 to 0.97, P=0.01).
CONCLUSIONS: The results of our study support the hypothesis that a higher cholesterol level favors development of minor strokes. Because of selection, therefore, major strokes are more often seen in patients with lower cholesterol levels. Poststroke mortality, therefore, is inversely related to cholesterol.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17761907     DOI: 10.1161/STROKEAHA.107.490292

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  26 in total

1.  Stroke: hyperlipidemia and cerebral small-vessel disease.

Authors:  Jessica R L Warsch; Clinton B Wright
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

2.  A study of serum apolipoprotein A1, apolipoprotein B and lipid profile in stroke.

Authors:  Shilpasree As; Savitri Sahukar; Jayaprakash Murthy; Kiran Kumar
Journal:  J Clin Diagn Res       Date:  2013-07-01

3.  Suboptimal lipid management before and after ischaemic stroke and TIA-the North Dublin Population Stroke Study.

Authors:  Danielle Ní Chróinín; Chantelle Ní Chróinín; Layan Akijian; Elizabeth L Callaly; Niamh Hannon; Lisa Kelly; Michael Marnane; Áine Merwick; Órla Sheehan; Gillian Horgan; Joseph Duggan; Lorraine Kyne; Eamon Dolan; Seán Murphy; David Williams; Peter J Kelly
Journal:  Ir J Med Sci       Date:  2018-01-24       Impact factor: 1.568

4.  Hyperlipidemia is associated with lower risk of poststroke mortality independent of statin use: A population-based study.

Authors:  Samrat Yeramaneni; Dawn O Kleindorfer; Heidi Sucharew; Kathleen Alwell; Charles J Moomaw; Matthew L Flaherty; Daniel Woo; Opeolu Adeoye; Simona Ferioli; Felipe de Los Rios La Rosa; Sharyl Martini; Jason Mackey; Pooja Khatri; Brett M Kissela; Jane C Khoury
Journal:  Int J Stroke       Date:  2016-09-24       Impact factor: 5.266

5.  Prognostic significance of major lipids in patients with acute ischemic stroke.

Authors:  Konstantinos Tziomalos; Vasilios Giampatzis; Stella D Bouziana; Marianna Spanou; Stavroula Kostaki; Maria Papadopoulou; Stella-Maria Angelopoulou; Maria Tsopozidi; Christos Savopoulos; Apostolos I Hatzitolios
Journal:  Metab Brain Dis       Date:  2016-10-23       Impact factor: 3.584

6.  Metabolic syndrome increases risk of venous thromboembolism recurrence after acute deep vein thrombosis.

Authors:  Lauren K Stewart; Jeffrey A Kline
Journal:  Blood Adv       Date:  2020-01-14

7.  Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.

Authors:  Mee Kyoung Kim; Kyungdo Han; Hun-Sung Kim; Yong-Moon Park; Hyuk-Sang Kwon; Kun-Ho Yoon; Seung-Hwan Lee
Journal:  Eur Heart J       Date:  2017-12-21       Impact factor: 29.983

8.  Biomarkers and functional outcomes from ischaemic cerebral events in women: a prospective cohort study.

Authors:  P M Rist; J E Buring; C S Kase; P M Ridker; T Kurth
Journal:  Eur J Neurol       Date:  2012-10-03       Impact factor: 6.089

9.  Trans-sodium crocetinate provides neuroprotection against cerebral ischemia and reperfusion in obese mice.

Authors:  Jiao Deng; Lize Xiong; Zhiyi Zuo
Journal:  J Neurosci Res       Date:  2014-12-09       Impact factor: 4.164

Review 10.  The role of cholesterol and statins in stroke.

Authors:  Babak B Navi; Alan Z Segal
Journal:  Curr Cardiol Rep       Date:  2009-01       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.